Functional interactions of HIV-infection and methamphetamine dependence during motor programming

Psychiatry Research - Neuroimaging

Volumn 202, Issue 1, 2012, Pages 46-52

  Archibald, Sarah L ^a   Jacobson, Mark W ^a,e   Fennema Notestine, Christine ^a,c   Ogasawara, Miki ^a   Woods, Steven P ^a   Letendre, Scott ^b   Grant, Igor ^a   Jernigan, Terry L ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Dopamine; Drug abuse; FMRI; Neuroimaging

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BOLD SIGNAL; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHAMPHETAMINE DEPENDENCE; MOTOR PERFORMANCE; NEUROIMAGING; PARIETAL CORTEX; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; TASK PERFORMANCE;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; BRAIN MAPPING; FEMALE; HIV SEROPOSITIVITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; MIDDLE AGED; MOTOR ACTIVITY; NERVE NET; NEURONS;

EID: 84862569704     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2012.03.006     Document Type: Article

References (41)

1. American Psychiatric Association DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC. 4th edition.
2. Archibald S.L., Masliah E., Fennema-Notestine C., Marcotte T.D., Ellis R.J., McCutchan J.A., Heaton R.K., Grant I., Mallory M., Miller A., Jernigan T.L. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Archives of Neurology 2004, 61:369-376.
3. Becker J.T., Sanders J., Madsen S.K., Ragin A., Kingsley L., Maruca V., Cohen B., Goodkin K., Martin E., Miller E.N., Sacktor N., Alger J.R., Barker P.B., Saharan P., Carmichael O.T., Thompson P.M. Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging and Behavior 2011, 5:77-85.
4. Becker J.T., Maruca V., Kingsley L.A., Sanders J.M., Alger J.R., Barker P.B., Goodkin K., Martin E., Miller E.N., Ragin A., Sacktor N., Selnes O. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 2012, 54:113-121.
5. Berger J.R., Arendt G. HIV dementia: the role of the basal ganglia and dopaminergic systems. Journal of Psychopharmacology 2000, 14:214-221.
6. Berger J.R., Kumar M., Kumar A., Fernandez J.B., Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 1994, 8:67-71.
7. Bogdanova Y., Neargarder S., Cronin-Golomb A. Mapping mental number line in physical space: vertical and horizontal visual number line orientation in asymptomatic individuals with HIV. Neuropsychologia 2008, 46:2914-2923.
8. Carey C.L., Woods S.P., Rippeth J.D., Gonzalez R., Heaton R.K., Grant I. Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS and Behavior 2006, 10:185-190.
9. Chana G., Everall I.P., Crews L., Langford D., Adame A., Grant I., Cherner M., Lazzaretto D., Heaton R., Ellis R., Masliah E. Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 2006, 67:1486-1489.
10. Chang L., Cloak C., Patterson K., Grob C., Miller E.N., Ernst T. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biological Psychiatry 2005, 57:967-974.
11. Chang L., Ernst T., Speck O., Grob C.S. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. The American Journal of Psychiatry 2005, 162:361-369.
12. Chao L.L., Cardenas V.A., Meyerhoff D.J., Rothlind J.C., Flenniken D.L., Lindgren J.A., Weiner M.W. Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy. Neuroreport 2003, 14:2111-2115.
13. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Computers and Biomedical Research 1996, 29:162-173.
14. Eisch A.J., O'Dell S.J., Marshall J.F. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 1996, 22:217-225.
15. Ferris M.J., Mactutus C.F., Booze R.M. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neuroscience & Biobehavioral Review 2008, 32:883-909.
16. Gonzalez R., Jacobus J., Amatya A.K., Quartana P.J., Vassileva J., Martin E.M. Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence. Neuropsychology 2008, 22:776-786.
17. Gross N.B., Marshall J.F. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience 2009, 161:1114-1125.
18. Heaton R.K., Marcotte T.D., Mindt M.R., Sadek J., Moore D.J., Bentley H., McCutchan J.A., Reicks C., Grant I. The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of International Neuropsychological Society 2004, 10:317-331.
19. Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010, 75:2087-2096.
20. Jernigan T.L., Archibald S., Hesselink J.R., Atkinson J.H., Velin R.A., McCutchan J.A., Chandler J., Grant I. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Archives of Neurology 1993, 50:250-255.
21. Jernigan T.L., Gamst A.C., Archibald S.L., Fennema-Notestine C., Mindt M.R., Marcotte T.D., Heaton R.K., Ellis R.J., Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. The American Journal of Psychiatry 2005, 162:1461-1472.
22. Klunder A.D., Chiang M.C., Dutton R.A., Lee S.E., Toga A.W., Lopez O.L., Aizenstein H.J., Becker J.T., Thompson P.M. Mapping cerebellar degeneration in HIV/AIDS. Neuroreport 2008, 19:1655-1659.
23. Kumar A.M., Fernandez J.B., Singer E.J., Commins D., Waldrop-Valverde D., Ownby R.L., Kumar M. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. Journal of Neurovirology 2009, 15:257-274.
24. Larsson M., Hagberg L., Forsman A., Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. Journal of Neuroscience Research 1991, 28:406-409.
25. LaVoie M.J., Card J.P., Hastings T.G. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Experimental Neurology 2004, 187:47-57.
26. Nordahl T.E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry and Clinical Neuroscience 2003, 15:317-325.
27. Pu C., Broening H.W., Vorhees C.V. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 1996, 23:328-334.
28. Rippeth J.D., Heaton R.K., Carey C.L., Marcotte T.D., Moore D.J., Gonzalez R., Wolfson T., Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of International Neuropsychological Society 2004, 10:1-14.
29. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. Journal of Neuroscience 1997, 17:8491-8497.
30. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. European Journal of Neuroscience 1999, 11:1598-1604.
31. Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., Stern Y., Albert S., Palumbo D., Kieburtz K., De Marcaida J.A., Cohen B., Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology 2002, 8:136-142.
32. Scott J.C., Woods S.P., Matt G.E., Meyer R.A., Heaton R.K., Atkinson J.H., Grant I. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychology Review 2007, 17:275-297.
33. Simon S.L., Dean A.C., Cordova X., Monterosso J.R., London E.D. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. Journal of Studies on Alcohol and Drugs 2010, 71:335-344.
34. Sullivan E.V., Rosenbloom M.J., Rohlfing T., Kemper C.A., Deresinski S., Pfefferbaum A. Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia. Brain Imaging and Behavior 2011, 5:12-24.
35. Thomas D.M., Francescutti-Verbeem D.M., Liu X., Kuhn D.M. Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment-an oligonucleotide microarray approach. Journal of Neurochemistry 2004, 88:380-393.
36. Thomas D.M., Francescutti-Verbeem D.M., Kuhn D.M. Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity. Journal of Neurochemistry 2009, 109:1745-1755.
37. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience 2004, 24:6028-6036.
38. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. Journal of Neuroscience 2001, 21:9414-9418.
39. Wang G.J., Chang L., Volkow N.D., Telang F., Logan J., Ernst T., Fowler J.S. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 2004, 127:2452-2458.
40. Woods S.P., Rippeth J.D., Conover E., Gongvatana A., Gonzalez R., Carey C.L., Cherner M., Heaton R.K., Grant I. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 2005, 19:35-43.
41. Woody G.E., Donnell D., Seage G.R., Metzger D., Marmor M., Koblin B.A., Buchbinder S., Gross M., Stone B., Judson F.N. Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug and Alcohol Dependence 1999, 53:197-205.